New mRNA cancer vaccine from Moderna trialled in British patients
A new mRNA cancer vaccine made by pharmaceutical firm Moderna is being trialled in British patients.
The mRNA technology – which was adapted to make Covid-19 jabs – works by helping the body recognise and fight cancer cells.
Experts believe these vaccines may lead to a new generation of “off-the-shelf” cancer therapies.
Once in the body, the mRNA (a genetic material) ‘teaches’ the immune system how cancer cells differ to healthy cells and mobilises it to destroy them.
Current immunotherapies are removing the invisibility cloak that makes cancer hide within the body, but this removal is very non-specific. The appeal of cancer vaccines is that you can make it
